PRH Files Amicus Brief to Supreme Court on Mifepristone via Telehealth
PRH files Supreme Court brief defending telehealth access to mifepristone as essential, safe, and lifesaving care.
OUR STATEMENT
On May 5, 2026, Physicians for Reproductive Health, represented by Fried, Frank, Harris, Shriver & Jacobson LLP, filed an amicus brief to the Supreme Court of the United States detailing how critical it is for patients to be able to access mifepristone for abortion care via telehealth and how requiring in person dispensing of mifepristone is medically unnecessary and places a dangerous burden on patients across the country.
PRH physician advocates Drs. Olivia Manayan, Aishat Olatunde, Avanthi Jayaweera, Emma Trawick, Bhaskari Burra, Tal Lee, Benjamin Brown, and Rachel Jensen provided their firsthand perspectives of how access to mifepristone both in person and via telehealth is medically essential and lifesaving.
The brief states:
“Requiring in-person mifepristone dispensation directly impacts PRH physicians’ ability to provide patients with a safe and effective medication that is part of the most commonly recommended medication regimen to end a pregnancy. PRH and its network can attest that mifepristone is an incredibly safe and effective drug, whether dispensed in-person or via mail or at a local pharmacy following a telehealth visit.
“By multiple objective measures, mifepristone—whether dispensed in-person, via mail, or at a local pharmacy—is very safe and effective. Consistent with the overwhelming medical consensus and literature, every doctor interviewed for this amicus brief prescribes mifepristone regularly and agrees that it is a safe and effective method for terminating pregnancy or managing pregnancy loss. None had medical concerns about dispensing mifepristone remotely…
“The inability to remotely access medication for abortion care and miscarriage management will constrain patients’ autonomy in deciding where, when, and how to manage their pregnancies and pregnancy losses, and will further erode physicians’ ability to provide preferred care to their patients, undermining physicians’ ability to exercise their judgment and core principles of medical ethics. For all these reasons, this Court should block the Fifth Circuit’s extraordinary stay.”
The post PRH Files Amicus Brief to Supreme Court on Mifepristone via Telehealth appeared first on Physicians for Reproductive Health.